INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

73,606 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
DD
DeSantis Deborah10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$6.94M
187.5K sh
Nov 21, 2025Nov 25, 2025
Page 1737 of 1841
← PrevNext →
traded Nov 21, 2025
+4d
SEC Form 4

Evidence

21
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$6.94M
187.5K sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

21
LS
Losyev SergeyCo-Chief Investment Officer
ARRArmour Residential REIT, Inc.
Option exercise
M—
1,500 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

21
MR
Marshak RichardChief Commercial Officer
TLSITriSalus Life Sciences, Inc.
Grant or award
A—
60.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

21
SJ
Stevens JenniferChief Regulatory Officer
TLSITriSalus Life Sciences, Inc.
Grant or award
A—
50.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

21
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J$6.94M
187.5K sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

20
GS
Garman Matthew SCEO Amazon Web Services
AMZNAMAZON COM INC
Open-market sale · 10b5-1 plan
SELL$840K
3,892 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

20
HI
Hyep IvanChief Financial Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$11K
605 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

19
RE
Reeve EmmaDirector
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$795K
10.0K sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

18
SS
Sharan SharatDirector, President and Chief Executive, 10% Owner
ONTFON24 INC.
Open-market sale · 10b5-1 plan
SELL$171K
32.2K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
DE
Dreyer EmilyChief Revenue Officer
TRUPTRUPANION, INC.
Option exercise
M—
1,341 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
MB
Mcgibney BrennaChief Administration Officer
TRUPTRUPANION, INC.
Option exercise
M—
1,881 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
CF
Cox Bryan F.Chief of Research
TLSITriSalus Life Sciences, Inc.
Grant or award
A—
40.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
MB
Mcgibney BrennaChief Administration Officer
TRUPTRUPANION, INC.
Option exercise
M—
1,354 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
PD
Patience DavidChief Financial Officer
TLSITriSalus Life Sciences, Inc.
Grant or award
A—
130.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
MR
Marshak RichardChief Commercial Officer
TLSITriSalus Life Sciences, Inc.
Grant or award
A—
120.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
GS
Garman Matthew SCEO Amazon Web Services
AMZNAMAZON COM INC
Open-market sale · 10b5-1 plan
SELL$91K
415 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

17
SG
Schneider Terrence G.VP, SUPPLY CHAIN
DGIIDIGI INTERNATIONAL INC
Grant or award
A—
5,345 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

17
SJ
Stevens JenniferChief Regulatory Officer
TLSITriSalus Life Sciences, Inc.
Grant or award
A—
100.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
FE
Freeland James E.VP, Chief Information Officer
DGIIDIGI INTERNATIONAL INC
Grant or award
A—
4,989 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

17
RA
Rahman Jill ADirector
AMCRAmcor plc
Option exercise
M—
15.2K sh
Nov 22, 2025Nov 25, 2025
traded Nov 22, 2025
+3dSEC Form 4

Evidence

17
MB
Mcgibney BrennaChief Administration Officer
TRUPTRUPANION, INC.
Tax withholding
F$26K
724 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
GR
Gallagher John RChief Operating Officer
TRUPTRUPANION, INC.
Option exercise
M—
3,328 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
MB
Mcgibney BrennaChief Administration Officer
TRUPTRUPANION, INC.
Option exercise
M—
1,250 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
PD
Patience DavidChief Financial Officer
TLSITriSalus Life Sciences, Inc.
Grant or award
A—
65.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
WS
Wheeler SimonEVP, Trupanion International
TRUPTRUPANION, INC.
Option exercise
M—
1,525 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
WS
Wheeler SimonEVP, Trupanion International
TRUPTRUPANION, INC.
Option exercise
M—
528 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
WS
Weinrauch SteveEVP, North Am & Vet Strategy
TRUPTRUPANION, INC.
Option exercise
M—
2,931 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
MD
Macauley DesmondCo-Chief Investment Officer
ARRArmour Residential REIT, Inc.
Option exercise
M—
1,500 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

17
DJ
Devlin JodiChief of Clinical Operations
TLSITriSalus Life Sciences, Inc.
Grant or award
A—
100.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
MB
Mcgibney BrennaChief Administration Officer
TRUPTRUPANION, INC.
Option exercise
M—
1,881 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
MB
Mcgibney BrennaChief Administration Officer
TRUPTRUPANION, INC.
Tax withholding
F$36K
1,006 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
QF
Qureshi FawwadChief Financial Officer
TRUPTRUPANION, INC.
Option exercise
M—
5,247 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
OT
Ostergaard TorbenCEO Spinnaker
HIPOHippo Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$112K
3,493 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

17
CF
Cox Bryan F.Chief of Research
TLSITriSalus Life Sciences, Inc.
Grant or award
A—
80.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

17
MP
Mohideen PharisChief Medical Officer
DBVTDBV Technologies S.A.
Open-market sale
SELL$4,498
1,624 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

16
GS
Goord Glenn SDirector
REKRRekor Systems, Inc.
Option exercise
M$63K
48.5K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

16
HW
House Rebecca WSVP, CLO and Secretary
ROKROCKWELL AUTOMATION, INC
Option exercise
M$98K
500 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

16
BL
Bonnot LionelSee Remarks
SITMSITIME Corp
Open-market sale · 10b5-1 plan
SELL$291K
1,078 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

16
LJ
Lin Sue-JeanDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M$54K
7,220 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence